Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Equities
600329
CNE000001808
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.96 CNY | -1.49% | -0.09% | +3.89% |
04-30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
04-30 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Recommends Dividend | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.89% | 3.16B | |
+43.33% | 6.3B | |
-16.78% | 4.44B | |
-6.93% | 3.27B | |
-0.88% | 2.58B | |
+46.64% | 1.96B | |
-5.34% | 1.73B | |
+1.60% | 1.68B | |
-7.31% | 1.63B | |
+47.94% | 1.53B |
- Stock Market
- Equities
- 600329 Stock
- News Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Tianjin Pharmaceutical Da Ren Tang's 2023 Profit Rises 14.5%